Clinical Trial Update: Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating the combination of tovorafenib with rituximab in patients with hairy cell leukemia, which is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• Rituximab (rituximab)
• tovorafenib (tovorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia | Phase 1, Phase 2 | Status: RECRUITING